Publications
- Zpráva z posledních analýz terapie Vidazou (azacitidin) a Revlimidem (lenalidomid) nemocných s myelodysplastickým syndromem v ČR - data z MyDyS registru2019 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- De novo accelerated phase of chronic myeloid leukemia should be recognized even in the era of tyrosine kinase inhibitors2024 | Central Library of Charles University, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Recommendations of the Czech Society of Haematology for the diagnosis and treatment of immune thrombocytopenia in adults2023 | Central Library of Charles University
- Léčebné postupy v hematologii 2020. Doporučení České hematologické společnosti České lékařské společnosti Jana Evangelisty Purkyně2020 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine, Second Faculty of Medicine
- Doporučení ČHS pro diagnostiku a léčbu imunitní trombocytopenie (ITP)2017 | Third Faculty of Medicine, Faculty of Medicine in Hradec Králové, First Faculty of Medicine
- Interferon-alpha Revisited: Individualized Treatment Management Eased the Selective Pressure of Tyrosine Kinase Inhibitors on BCR-ABL1 Mutations Resulting in a Molecular Response in High-Risk CML Patients2016 | Third Faculty of Medicine, Faculty of Science, First Faculty of Medicine
- Efficacy of rituximab in primary immune thrombocytopenia: An analysis of adult pretreated patients from everyday hematological practice2012 | Central Library of Charles University, Third Faculty of Medicine, Faculty of Medicine in Hradec Králové
Loading network view...